Cargando…
Frequency of Human Platelet Antigens –1 to –5 and –15 in Turkmen Blood Donors
BACKGROUND: Due to the presence of platelet antigen polymorphisms, human platelet membrane glycoproteins can be identified as an alloantigen or autoantigen. The aim of this study was to determine the frequencies of human platelet antigens (HPAs)-1 to-5 and-15 in Turkmen blood donors and establish a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086666/ https://www.ncbi.nlm.nih.gov/pubmed/37057228 http://dx.doi.org/10.4103/abr.abr_282_21 |
_version_ | 1785022199729487872 |
---|---|
author | Nozarimirarkolaei, Maedeh Dadashi, Maryam Ghasemi, Ali Samiee, Shahram Shaeigan, Mojgan Zadsar, Maryam |
author_facet | Nozarimirarkolaei, Maedeh Dadashi, Maryam Ghasemi, Ali Samiee, Shahram Shaeigan, Mojgan Zadsar, Maryam |
author_sort | Nozarimirarkolaei, Maedeh |
collection | PubMed |
description | BACKGROUND: Due to the presence of platelet antigen polymorphisms, human platelet membrane glycoproteins can be identified as an alloantigen or autoantigen. The aim of this study was to determine the frequencies of human platelet antigens (HPAs)-1 to-5 and-15 in Turkmen blood donors and establish a panel of accredited HPAs negative donors as well as an HPA-typed platelet donor registry. MATERIALS AND METHODS: HPA-1 to-5 and-15 typing was performed by the polymerase chain reaction-sequence-specific primer techniques on 80 unrelated Turkmen donors who were referred to Aq-Qala Blood Transfusion Center in Golestan Province from September 2018 to October 2019. RESULTS: The frequencies of HPA phenotypes were determined as follows: HPA-1aa: 92.5%, HPA-1ab: 7.5%, HPA-2aa: 77.5%, HPA-2ab: 20.0%, HPA-2bb: 2.5%, HPA-3aa: 75.3%, HPA-3ab: 50%, HPA-3bb: 11.2%, HPA-4aa: 100%, HPA-5aa: 78.5%, HPA-5ab: 21.5%, HPA-15aa: 41.2%, HPA-15ab: 56.2% and HPA-15bb: 17.5%. CONCLUSION: Determining the genotype of HPAs that play an important role in platelet refractory can improve the management of alloimmunization due to the incompatibility of HPAs between the recipients and donors. Therefore, the registration process for national platelet donors can help patients accelerate and improve the quality of transfused platelets. |
format | Online Article Text |
id | pubmed-10086666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-100866662023-04-12 Frequency of Human Platelet Antigens –1 to –5 and –15 in Turkmen Blood Donors Nozarimirarkolaei, Maedeh Dadashi, Maryam Ghasemi, Ali Samiee, Shahram Shaeigan, Mojgan Zadsar, Maryam Adv Biomed Res Original Article BACKGROUND: Due to the presence of platelet antigen polymorphisms, human platelet membrane glycoproteins can be identified as an alloantigen or autoantigen. The aim of this study was to determine the frequencies of human platelet antigens (HPAs)-1 to-5 and-15 in Turkmen blood donors and establish a panel of accredited HPAs negative donors as well as an HPA-typed platelet donor registry. MATERIALS AND METHODS: HPA-1 to-5 and-15 typing was performed by the polymerase chain reaction-sequence-specific primer techniques on 80 unrelated Turkmen donors who were referred to Aq-Qala Blood Transfusion Center in Golestan Province from September 2018 to October 2019. RESULTS: The frequencies of HPA phenotypes were determined as follows: HPA-1aa: 92.5%, HPA-1ab: 7.5%, HPA-2aa: 77.5%, HPA-2ab: 20.0%, HPA-2bb: 2.5%, HPA-3aa: 75.3%, HPA-3ab: 50%, HPA-3bb: 11.2%, HPA-4aa: 100%, HPA-5aa: 78.5%, HPA-5ab: 21.5%, HPA-15aa: 41.2%, HPA-15ab: 56.2% and HPA-15bb: 17.5%. CONCLUSION: Determining the genotype of HPAs that play an important role in platelet refractory can improve the management of alloimmunization due to the incompatibility of HPAs between the recipients and donors. Therefore, the registration process for national platelet donors can help patients accelerate and improve the quality of transfused platelets. Wolters Kluwer - Medknow 2023-02-25 /pmc/articles/PMC10086666/ /pubmed/37057228 http://dx.doi.org/10.4103/abr.abr_282_21 Text en Copyright: © 2023 Advanced Biomedical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Nozarimirarkolaei, Maedeh Dadashi, Maryam Ghasemi, Ali Samiee, Shahram Shaeigan, Mojgan Zadsar, Maryam Frequency of Human Platelet Antigens –1 to –5 and –15 in Turkmen Blood Donors |
title | Frequency of Human Platelet Antigens –1 to –5 and –15 in Turkmen Blood Donors |
title_full | Frequency of Human Platelet Antigens –1 to –5 and –15 in Turkmen Blood Donors |
title_fullStr | Frequency of Human Platelet Antigens –1 to –5 and –15 in Turkmen Blood Donors |
title_full_unstemmed | Frequency of Human Platelet Antigens –1 to –5 and –15 in Turkmen Blood Donors |
title_short | Frequency of Human Platelet Antigens –1 to –5 and –15 in Turkmen Blood Donors |
title_sort | frequency of human platelet antigens –1 to –5 and –15 in turkmen blood donors |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086666/ https://www.ncbi.nlm.nih.gov/pubmed/37057228 http://dx.doi.org/10.4103/abr.abr_282_21 |
work_keys_str_mv | AT nozarimirarkolaeimaedeh frequencyofhumanplateletantigens1to5and15inturkmenblooddonors AT dadashimaryam frequencyofhumanplateletantigens1to5and15inturkmenblooddonors AT ghasemiali frequencyofhumanplateletantigens1to5and15inturkmenblooddonors AT samieeshahram frequencyofhumanplateletantigens1to5and15inturkmenblooddonors AT shaeiganmojgan frequencyofhumanplateletantigens1to5and15inturkmenblooddonors AT zadsarmaryam frequencyofhumanplateletantigens1to5and15inturkmenblooddonors |